S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
The single greatest medical breakthrough of all time? (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
A coal mine fire in southern China's Guizhou province kills 16 people
NASDAQ:ONVO

Organovo (ONVO) Stock Forecast, Price & News

$1.33
-0.09 (-6.34%)
(As of 09/22/2023 ET)
Compare
Today's Range
$1.29
▼
$1.48
50-Day Range
$1.06
▼
$1.90
52-Week Range
$1.00
▼
$3.40
Volume
47,222 shs
Average Volume
66,936 shs
Market Capitalization
$11.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

ONVO stock logo

About Organovo (NASDAQ:ONVO) Stock

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

ONVO Price History

ONVO Stock News Headlines

September 21, 2023 | americanbankingnews.com
Organovo (NASDAQ:ONVO) Coverage Initiated at StockNews.com
September 14, 2023 | americanbankingnews.com
Organovo (NASDAQ:ONVO) Receives New Coverage from Analysts at StockNews.com
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
September 8, 2023 | finance.yahoo.com
Organovo to Participate in the H.C. Wainwright Global Investment Conference
August 25, 2023 | finance.yahoo.com
Is Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
August 23, 2023 | finance.yahoo.com
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
August 16, 2023 | msn.com
Onvo receives $3 million grant from PennDOT to enhance electric vehicle charging infrastructure
July 29, 2023 | seekingalpha.com
ONVO Organovo Holdings, Inc.
September 24, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
July 20, 2023 | msn.com
Onvo introduces first public fast electric vehicle chargers on I-81 stretch
June 7, 2023 | fool.com
Organovo (NASDAQ: ONVO)
March 21, 2023 | finance.yahoo.com
Organovo Announces FXR Program
February 10, 2023 | finance.yahoo.com
Will Organovo Holdings (NASDAQ:ONVO) Spend Its Cash Wisely?
October 25, 2022 | finance.yahoo.com
Organovo Holdings, Inc. (ONVO)
October 17, 2022 | finance.yahoo.com
Trends in 3D-Printing Materials Technology and the Global Market for the Most Promising New 3D-Printing Materials Applications - Yahoo Finance
October 12, 2022 | benzinga.com
Human Liver Models Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | D - Benzinga
October 9, 2022 | globenewswire.com
3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market - GlobeNewswire
October 3, 2022 | seekingalpha.com
ARKG: Too Hard To Pin Down, Too Volatile For Comfort (BATS:ARKG) - Seeking Alpha
September 30, 2022 | prnewswire.com
Global Laboratory Animal Models, 3D Cultures and Organoids Markets, 2019-2021 & 2022-2027 - Opportunities in Organoids in Drug Development, Personalized Medicine and Transplantational Medicine - PR Newswire
September 30, 2022 | businesswire.com
Global Human Liver Model Market Report 2022: Emerging 3D and 2D Trends in Modeling Human Liver Disease in Vitro Fuel Growth - ResearchAndMarkets.com - Business Wire
September 29, 2022 | businesswire.com
3D Bioprinting Global Market Report 2022: Long-term Forecasts to 2026 & 2031 Featuring Organovo Holdings, Allevi, Cellink, Aspect Biosystems, & 3D Systems - ResearchAndMarkets.com - Business Wire
September 23, 2022 | benzinga.com
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket - American Vir - Benzinga
September 22, 2022 | uk.investing.com
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UK
September 16, 2022 | nasdaq.com
Pre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - Nasdaq
September 16, 2022 | uk.investing.com
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket By Benzinga - Investing.com UK
September 14, 2022 | rttnews.com
Pre-market Movers: DWIN, SES, KSPN, NRBO, EPM… - RTTNews
September 6, 2022 | globenewswire.com
Organovo Announces Postponement of Annual Meeting of Stockholders - GlobeNewswire
See More Headlines
Receive ONVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organovo and its competitors with MarketBeat's FREE daily newsletter.

ONVO Company Calendar

Last Earnings
8/10/2023
Today
9/24/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
3/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ONVO
CUSIP
N/A
CIK
1497253
Web
www.organovo.com
Phone
(858) 224-1000
Fax
N/A
Employees
23
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($2.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,260,000.00
Net Margins
-4,061.12%
Pretax Margin
-4,060.67%
Return on Equity
-97.16%
Return on Assets
-82.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.61
Quick Ratio
6.61

Sales & Book Value

Annual Sales
$370,000.00
Price / Sales
31.34
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.76 per share
Price / Book
0.76

Miscellaneous

Outstanding Shares
8,720,000
Free Float
8,369,000
Market Cap
$11.60 million
Optionable
Optionable
Beta
0.88
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover
10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Keith E. Murphy (Age 51)
    Exec. Chairman
    Comp: $626.24k
  • Ms. Vaidehi Joshi (Age 36)
    Director of Discovery Biology & Director
    Comp: $91.4k
  • Mr. Thomas P. Hess CPA (Age 59)
    MBA, Pres & CFO
  • Dr. Curtis M. Tyree Ph.D.
    Sr. VP of Strategy & Bus. Devel.

Key Competitors

View All Competitors













ONVO Stock - Frequently Asked Questions

How have ONVO shares performed in 2023?

Organovo's stock was trading at $1.41 at the beginning of the year. Since then, ONVO stock has decreased by 5.7% and is now trading at $1.33.
View the best growth stocks for 2023 here.

When is Organovo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our ONVO earnings forecast.

How were Organovo's earnings last quarter?

Organovo Holdings, Inc. (NASDAQ:ONVO) posted its quarterly earnings data on Thursday, August, 10th. The medical research company reported ($0.46) EPS for the quarter. The medical research company had revenue of $0.08 million for the quarter. Organovo had a negative net margin of 4,061.12% and a negative trailing twelve-month return on equity of 97.16%.

When did Organovo's stock split?

Shares of Organovo reverse split on Wednesday, August 19th 2020. The 1-20 reverse split was announced on Monday, August 17th 2020. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, August 18th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Taylor Crouch's approval rating as Organovo's CEO?

3 employees have rated Organovo Chief Executive Officer Taylor Crouch on Glassdoor.com. Taylor Crouch has an approval rating of 38% among the company's employees. This puts Taylor Crouch in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Organovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organovo investors own include Brainstorm Cell Therapeutics (BCLI), NVIDIA (NVDA), Aerojet Rocketdyne (AJRD), Blackstone (BX), LADENBURG THALM/SH SH (LTS), Advanced Micro Devices (AMD), Exelixis (EXEL), Micron Technology (MU), Novavax (NVAX) and OPKO Health (OPK).

What is Organovo's stock symbol?

Organovo trades on the NASDAQ under the ticker symbol "ONVO."

How do I buy shares of Organovo?

Shares of ONVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organovo's stock price today?

One share of ONVO stock can currently be purchased for approximately $1.33.

How much money does Organovo make?

Organovo (NASDAQ:ONVO) has a market capitalization of $11.60 million and generates $370,000.00 in revenue each year. The medical research company earns $-17,260,000.00 in net income (profit) each year or ($2.06) on an earnings per share basis.

How can I contact Organovo?

Organovo's mailing address is 440 STEVENS AVENUE SUITE 200, SOLANA BEACH CA, 92075. The official website for the company is www.organovo.com. The medical research company can be reached via phone at (858) 224-1000 or via email at ir@organovo.com.

This page (NASDAQ:ONVO) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -